NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

“Perhaps it is the cost and no insurance coverage.”

Of course, I have been saying this for over 2 years now. I have been living and breathing this world for 20 years! Even approvals alone will not result in wider adoption due to costs. Reimbursements are critical. There will be a ton of challenges on the reimbursement front as well. It won’t be an easy battle! Qualification criteria, cost limit, and other negotiations won’t be easy.

Plus adoption even after approvals and reimbursements will not be as quick as everyone expects here. That’s just the nature of clinical therapy world. This is already quite challenging for a big established player with a ton of resources. So NWBO will not be able to do justice on their own for sure. It will take years if they remain independent.